Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 258, pseudogene (RN7SL258P)

Target
RN7SL258P
Molecular classification
Pseudogene, Non-coding RNA, 7SL RNA-related (Signal recognition particle-related sequence)
01

Overview

RN7SL258P is a human pseudogene sequence related to the 7SL RNA component of the signal recognition particle (SRP)[3][7][4]. The original 7SL RNA acts as a scaffold within the SRP, which mediates co-translational targeting of nascent secretory and membrane proteins to the endoplasmic reticulum[1][5]. The RN7SL258P locus reflects a non-functional, non-coding remnant of this system, generated through reverse transcription and integration back into the genome as a defective or truncated version of the original gene[3]. Pseudogenes, including RN7SL258P, are typically considered "genomic fossils" but may under some circumstances have regulatory functions—such as involvement in RNA interference or as microRNA sponges. However, no specific biological function or disease association has been reported for RN7SL258P[6][7]. RN7SL pseudogenes are numerous in the human genome and are commonly associated with Alu repeat elements[1][3]. There is no evidence that RN7SL258P is involved in any pharmacological mechanism, nor does it serve as a biomarker or therapeutic target. Summary: RN7SL258P is a human non-coding pseudogene related to 7SL RNA. It is not considered a therapeutic target, has no established biological function or disease role, and is not actionable by known drugs[3][6][7].

Other names
RN7SL258PRNA, 7SL, cytoplasmic 258, pseudogeneHGNC: 46274NCBI Gene: 106480373Ensembl: ENSG00000240589
02

Mechanism of action

Not applicable; does not serve as a drug target

03

Biological functions

None established; as a pseudogene, RN7SL258P does not encode a functional productSome pseudogenes have regulatory roles via RNA interference or as microRNA decoys, but there are no specific functional annotations for RN7SL258P itself
04

Disease associations

No specific disease association for RN7SL258PGeneral note: pseudogene deregulation has been linked to cancer and other diseases through regulatory effects on gene expression, but this role is not demonstrated for RN7SL258P
05

Safety considerations

None known; as a pseudogene, RN7SL258P is not known to pose therapeutic safety challenges

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 258, pseudogene (RN7SL258P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 258, pseudogene (RN7SL258P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call